Association of Sleep-Disordered Breathing With Cognitive Function and Risk of Cognitive Impairment: A Systematic Review Meta-analysis by Leng, Yue et al.
Association of Sleep-Disordered Breathing With Cognitive Function
and Risk of Cognitive Impairment: A Systematic Review Meta-analysis
Leng, Y., McEvoy, C., Allen, I., & Yaffe, K. (2017). Association of Sleep-Disordered Breathing With Cognitive
Function and Risk of Cognitive Impairment: A Systematic Review Meta-analysis. DOI:
10.1001/jamaneurol.2017.2180
Published in:
JAMA neurology
Document Version:
Publisher's PDF, also known as Version of record
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
© 2017 American Medical Association. This work is made available online in accordance with the publisher’s policies. Please refer to any
applicable terms of use of the publisher.
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:09. Sep. 2018
Association of Sleep-Disordered BreathingWith Cognitive
Function and Risk of Cognitive Impairment
A Systematic ReviewMeta-analysis
Yue Leng, PhD; Claire T. McEvoy, PhD; Isabel E. Allen, PhD; Kristine Yaffe, MD
IMPORTANCE Growing evidence suggests an association between sleep-disordered breathing
(SDB) and cognitive decline in elderly persons. However, results from population-based
studies have been conflicting, possibly owing to different methods to assess SDB or cognitive
domains, making it difficult to draw conclusions on this association.
OBJECTIVE To provide a quantitative synthesis of population-based studies on the
relationship between SDB and risk of cognitive impairment.
DATA SOURCES PubMed, EMBASE, and PsychINFOwere systematically searched to identify
peer-reviewed articles published in English before January 2017 that reported on the
association between SDB and cognitive function.
STUDY SELECTION We included cross-sectional and prospective studies with at least 200
participants with a mean participant age of 40 years or older.
DATA EXTRACTION AND SYNTHESIS Data were extracted independently by 2 investigators.
We extracted and pooled adjusted risk ratios from prospective studies and standardmean
differences from cross-sectional studies, using random-effect models. This meta-analysis
followed the PRISMA guidelines and also adhered to theMOOSE guidelines.
MAIN OUTCOMES ANDMEASURES Cognitive outcomeswere based on standard tests or
diagnosis of cognitive impairment. Sleep-disordered breathing was ascertained by
apnea-hypopnea index or clinical diagnosis.
RESULTS We included 14 studies, 6 of which were prospective, covering a total of 4 288419
men and women. Pooled analysis of the 6 prospective studies indicated that those with SDB
were 26% (risk ratio, 1.26; 95% CI, 1.05-1.50) more likely to develop cognitive impairment,
with no evidence of publication bias but significant heterogeneity between studies. After
removing 1 study that introduced significant heterogeneity, the pooled risk ratio was 1.35
(95% CI, 1.11-1.65). Pooled analysis of the 7 cross-sectional studies suggested that those with
SDB had slightly worse executive function (standardmean difference, −0.05; 95% CI, −0.09
to 0.00), with no evidence of heterogeneity or publication bias. Sleep-disordered breathing
was not associated with global cognition or memory.
CONCLUSIONS AND RELEVANCE Sleep-disordered breathing is associatedwith an increased
risk of cognitive impairment and a small worsening in executive function. Further studies are
required to determine themechanisms linking these common conditions and whether
treatment of SDBmight reduce risk of cognitive impairment.
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S leep-disordered breathing (SDB) is a very common buttreatable condition inolder adults.Therehasbeengrow-ing interest in the relationship between SDB and ad-
verse health consequences, including hypertension, diabe-
tes, and cardiovascular diseases.1-4 While the association
between SDB andhealth outcomes remains controversial, es-
pecially in older populations,5-8 recent evidence has sug-
gested a link between SDB and cognitive decline in elderly
persons.9-11Notably,most early studieshaveexamined the as-
sociation between SDB and cognition in clinical populations,
eg, among patients at sleep clinics.12-14 These studies usually
consist of individualswith relatively severe SDBandwere lim-
itedby small sample sizes and failure to account for confound-
ing factors.
Over the past few years, an increasing number of popula-
tion-based studies have been conducted on SDB and cogni-
tive impairment.15-17 These community-dwelling samples of-
ten include individuals withmilder SDB, as opposed to those
examined in case-control studies. Some of these studies sug-
gested that SDBwas associatedwith increased risk of demen-
tiaor impairmentacrossdifferentcognitivedomains,18-20while
others found no association.17,21 Owing to different study de-
signs and methods to assess SDB, it is difficult to draw con-
clusions on the consistencyof the associations.Moreover, be-
cause each study has reported on specific domains using
different scales, it is unclear if SDB has differential effects on
cognitivedomains.Therefore, ameta-analytic approach ispar-
ticularly useful for synthesizing these studies and elucidat-
ing pooled estimates for the effects of SDB on risk of cogni-
tive impairment as well as effects across different cognitive
domains. Given the high prevalence of cognitive impairment
in elderly persons and its significant consequences,22,23 it is
critical to explore the role of SDB as a modifiable risk factor.
Methods
Search Strategy and Study Selection
We searched for articles published before January 2017 using
electronic databases, including PubMed, EMBASE, and
PsychINFO, and hand searched the reference lists of identi-
fied articles. Studies were identified using the search terms
“(sleep-disordered breathing OR sleep apnea OR obstructive
sleep apnea) AND (cognitionOR cognitive functionOR cogni-
tivedeclineORdementiaORAlzheimer’sORcognitive impair-
ment).” The search was restricted to articles published in
English. Studies were included if they (1) were original ar-
ticles published in a peer-reviewed journal; (2) used a cross-
sectional or prospective cohort design; (3) were conducted in
population-based samples (N ≥ 200; mean age ≥40 years);
(4) defined SDBby apnea-hypopnea index (AHI) or clinical di-
agnosis by International Classification of Diseases, Ninth Re-
vision (ICD-9) codes; (5) incorporated outcomes on Alzhei-
mer disease (AD), dementia risk, or cognitive impairment, as
defined by validated cognitive tests; (6) reported effect esti-
mates appropriate for the pooled analysis of effect sizes (eg,
odds ratios [ORs], hazard ratios, mean differences, or stan-
dardizedmean differences [SMDs] in cognitive test scores) or
other types of estimates (eg, correlation or regression coeffi-
cient) that could be converted to the above forms; and (7) pre-
sented results adjusted for covariates (at least by age, sex, and
education). Studies were excluded if they (1) were case re-
ports, abstracts, reviews, or meta-analyses; (2) were con-
ducted in clinical populations; (3) used case-control design;
(4) used self-reported SDB; or (5) reported the prevalence of
SDB rather than studying SDB as a risk factor.
Data Extraction& Cognitive Outcomes
The eligibility of the studies to be included in the analysiswas
determined and data were extracted independently by 2 in-
vestigators (Y.L. and C.T.M.). If multiple articles were pub-
lished from the same cohort reporting on the same cognitive
outcomes, we included only the one with themost complete
details; if multiple articles from the same cohort had differ-
ent studydesignsor if they reportedondifferent cognitiveout-
comes, we included each of these articles separately in the
analysis. Differences in data extraction between the extrac-
tors were resolved by consensus discussion and consultation
with a third investigator (K.Y.).
Becausemost prospective studies reported theORorhaz-
ard ratio for cognitive impairment,15,18,24-26 risk ratio esti-
mates were extracted from these studies. To quantify the as-
sociation between SDB and different cognitive domains, we
extracted the adjusted cognitive test scores from the cross-
sectional studies.17,27-30 We also obtained adjusted estimates
fromNikodemova et al31 andHrubos-Strømet al32 by contact-
ing the study authors. To be included in the pooled analysis,
a cognitivedomainhas tobe representedbymore than3 stud-
ies; thus, we focused on 3 cognitive domains: global func-
tion, delayedmemory (unless the study only assessed imme-
diatememory), andexecutive function.Thesedomainsarealso
particularly important in the context of aging and develop-
ment of AD. The cognitive tests included from each study are
summarized in Table 1 and Table 2.
Definition of SDB
Weincludedstudies thatusedAHIor ICD-9codes todefineSDB.
Apnea-hypopnea index is theaveragenumberofapneaandhy-
popnea events per hour of sleep. In general, hypopnea is de-
finedasadiscerniblereductionintheairflowfollowedbyat least
a 4% reduction in oxyhemoglobin saturation (AHI4%), at least
Key Points
Question What are the effects of sleep-disordered breathing
(SDB) on cognitive function and risk of cognitive impairment?
Findings In this systematic reviewmeta-analysis that included
more than 4million participants, those with SDBwere 26%more
likely to develop cognitive impairment than those without SDB.
They also had slightly worse performance in executive function
but not in global cognition or memory.
Meaning Sleep-disordered breathingmay be an important
modifiable risk factor for dementia and other cognitive
impairment; future studies are needed to examine if treatment
of SDBmight reduce risk of cognitive impairment.
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a 3% reduction (AHI3%), or an event-related arousal (AHI3a).
Because there was a mixed use of these definitions in the in-
cluded studies, we first presented narrative description of the
definitions, and for themainanalysis,wepooled theestimates
by AHI less than 15 and 15 or greater to be consistent with the
most commonly used cutoff33 and to provide a most general-
izablecategorization.Forstudies thathavefurtherbrokendown
these 2 categories,17,25,27-29,32 we calculated a weighted mean
for AHI less than 15 and 15 or greater. For other studies16,29,30
that did not provide sufficient information for analysis by this
cutoff, we contacted study authors or used other literature to
obtain necessary information for the calculation.
Statistical Analysis
We pooled risk ratios to summarize the prospective relation-
ship between SDB and cognitive impairment. One prospec-
tive study17 reported thechanges in z scoresof 3 cognitive tests
that were strongly associated with AD or vascular dementia;
we converted themean z scores of these tests into a single risk
ratio using the onlinemeta-analysis calculator (David B.Wil-
son, PhD;http://www.campbellcollaboration.org/escalc/html
/EffectSizeCalculator-OR5.php).
For cross-sectional studies, we calculated SMD in cogni-
tive test scores by SDB status. In cases where a higher score
indicatedworsecognition,wemultiplied thescoreby−1so that
high scores indicated better performance across all tests. One
study34 only reported the OR, and this was converted to
Cohen d using the formula SMD = log(OR) ×3 / π. For one
study29where neither the SDsnor the 95%CIswere reported,
weused theSDof the same test fromanotherprevious study.21
Toestimate thepooledSMDforeachcognitivedomain,we first
calculateda summaryHedges gestimate for eachdomain from
each individual source study. This step ensures thatmultiple
relevant testswithin each source studywere all considered in
theanalysiswithoutbeingoverrepresented inthepooledanaly-
sis.All effect estimateswere thenpooledusingaweighted ran-
dom-effects model.
Wetestedbetween-studyheterogeneityusing I2 statistics35
and used Egger test and funnel plot asymmetry to evaluate
publication bias.36 All testswere 2-tailed. Sensitivity analysis
was conducted by excluding the studies that introduced sig-
nificant heterogeneity to the analysis on each cognitive out-
come. The quality of the included studies was evaluated in-
dependently by 2 investigators (Y.L. and C.T.M.) using the
Newcastle-OttawaQuality Assessment Scale.37 Our study ad-
heres to the Preferred Reporting Items for Systematic Re-
viewsandMeta-Analyses (PRISMA)guidelines38 and theMeta-
analysis of Observational Studies in Epidemiology (MOOSE)
checklist.39 All statistical analysis was performed using Re-
view Manager Software version 5 (Cochrane Collaboration).
Significance was set at P < .05.
Results
Literature Search and Study Characteristics
We identified a total of 3527 articles, including 1347 articles
from PubMed, 359 from PsychINFO, and 1821 from EMBASE.Ta
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After screening titles andabstracts,we selected 134articles for
further evaluation, and after applying the inclusion and ex-
clusion criteria, we retrieved 24 full-text articles for detailed
review. After excluding studies with insufficient data for the
meta-analysis, ouranalytic sample included14studies15-18,24-33
with4288419participants from5different countries (10 stud-
ies from the United States and 1 each from France, Germany,
Norway, andTaiwan) (eFigure in theSupplement). Table 1 and
Table 2 summarize the characteristics andNewcastle-Ottawa
Quality Assessment Scale quality scores of included studies.
TwostudiesofdifferentdesignswerepublishedfromtheStudy
of Osteoporotic Fractures,18,30 which recruited women only,
and another 2 from theOsteoporotic Fractures inMen,15,27 fo-
cusingonmenonly.Moreover, 2 studieswere basedon theUS
Veterans Affairs healthmedical records and included primar-
ilymen.26,33ThreestudiesusedclinicallydiagnosedSDB,24,26,33
while the rest presented results by AHI cutoffs15,17,18,21,25,27-32
or by continuous scores.16 Four studies17,29,31,32 used AHI4%
for the definition of SDB, 6 studies15,16,18,25,27,30 used AHI3%,
and 1 study28 did not specify the definition of AHI.
Prospective Studies of SDB and Risk
of Cognitive Impairment
Pooledanalysis of the6prospective studies (including212943
participants) indicated that thosewith SDBwere 26% (risk ra-
tio, 1.26; 95% CI, 1.05-1.50) more likely to develop cognitive
impairment, defined by clinically relevant cognitive
decline15,17,25 or risk of dementia,18,24,26 with no evidence of
publication bias but significant between-study heteroge-
neity (Figure 1). The 3 prospective studies that showed posi-
tive findings all examined risk of mild cognitive impairment
(MCI) or dementia as the outcome,18,24,26 and 2 of these used
ICD-9 codes todefineSDB.24,26 Sensitivity analysis shows that
after removing the study by Blackwell et al15 from this pooled
analysis, the heterogeneity disappeared (risk ratio, 1.35; 95%
CI, 1.11-1.65).
Cross-sectional Studies
Global Cognition
Pooled analysis of 6 cross-sectional studies (including
4073 604 participants) suggested that SDB was not signifi-
cantly associated with global cognition (SMD, −0.02; 95% CI,
−0.07 to 0.04) (Figure 2A). There was no evidence of publi-
cationbias but significant heterogeneity between studies. Af-
ter removing the study by Sharafkhaneh et al,33 the heteroge-
neity disappeared (SMD, 0.01; 95% CI, −0.04 to 0.05).
Executive Function
Pooled analysis of 7 cross-sectional studies (including 15 220
participants) indicated that thosewith SDB hadworse execu-
tive function comparedwith thosewithout (SMD, −0.05; 95%
CI,−0.09to0.00) (Figure2B).Therewasnoevidenceofhetero-
geneity or publication bias.
Memory
Figure 2C shows the relationship between SDB andmemory.
One studyonlyexamined immediatememory,32while the rest
assessed delayed recall.16,17,28,31 Pooled analysis of 5 cross-
sectional studies (including 11 863 participants) indicated an
SMD of −0.01 (95% CI, −0.05 to 0.04) in memory score be-
tween thosewith andwithout SDB. Therewas no evidence of
heterogeneity or publication bias.
Discussion
To our knowledge, this study is the first to provide a compre-
hensive systematic reviewandquantitative synthesis ofpopu-
lation-based studies onSDBand cognitive function and to ob-
tain pooled estimates of the effects of SDB on both the risk of
cognitive impairment and on different domains of cognitive
function. Our pooled analysis of more than 4 million adults
showed that those with SDB were 26% (risk ratio, 1.26; 95%
CI, 1.05-1.50)more likely todevelopcognitive impairment and
had slightlyworse performance in executive function but not
on global cognition or memory. Although some between-
study heterogeneity was found, sensitivity analysis con-
firmed these associations, and therewas no evidence of pub-
lication bias.
Our findings provide evidence that SDBmaybe an impor-
tant modifiable risk factor for cognitive impairment in el-
derly persons. Notably, a 2017 study40 suggested that SDB
might lead to early but possibly modifiable AD biomarker
changes. Our results are also supported by a 2016 meta-
analysis of case-control studies,41 which suggested that pa-
tients with ADwere 5-foldmore likely to have SDB compared
with cognitively intact individuals of similar age. In ourmeta-
analysis, the3prospectivestudies18,24,26 thatexaminedtherisk
Figure 1. Forest Plot of Prospective Studies on Association Between Sleep-Disordered Breathing and Risk
of Cognitive Impairment
Weight, %
0.5 3.02.01.0
OR (95% CI)
Study OR (95% CI)
23.7Blackwell et al,15 2015 0.99 (0.80-1.23)
17.1Chang et al,24 2013 1.70 (1.24-2.32)
10.9Lutsey et al,17 2016 0.99 (0.63-1.55)
5.2Martin et al,25 2015 1.28 (0.62-2.65)
9.2Yaffe et al,18 2011 1.86 (1.12-3.09)
33.9Yaffe et al,26 2015 1.23 (1.14-1.33)
Total (95% CI) 1.26 (1.05-1.50)
0.7
All effect estimates were pooled
using a weighted random-effects
model. Heterogeneity: Τ2 = 0.02;
χ2 = 11.40; df = 5; P = .04; I2 = 56%.
Test for overall effect: z = 2.51;
P = .01. Error bars indicate 95% CIs.
OR indicates odds ratio.
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ofMCI or dementia as the outcomes showed significant asso-
ciations while the other 3 studies15,17,25 that did not find any
association all defined cognitive impairment as a significant
cognitive decline. This could be owing to the differences in
these cognitive outcomes, given that the severity of cognitive
impairment indicated by even a significant decline in cogni-
tive scoresmight not be comparablewith that of clinically di-
agnosed MCI or dementia. It is also possible that SDB might
beparticularly important through the course of conversion to
MCI or dementia. However, to our knowledge, the underly-
ing cause of this observation has yet to be determined. Fur-
thermore, studies that found significant results mostly used
clinicaldiagnosisofSDBrather thananAHIof 15orgreater.24,26
This could be because the more severe cases are more likely
to be detected and less likely to be misclassified or because
there exist mechanistic pathways through which severe
SDB could particularly impair cognition. Sensitivity analysis
showed similar results after removing the study15 that intro-
duced significant heterogeneity to thepooled analysis of pro-
spective studies. This heterogeneitymight be because of spe-
cific characteristics of the study sample (all older men)15 or
relatively short follow-up length compared with other simi-
lar studies.17,25
Thepooledanalysisof cross-sectional studies suggests that
there was a modest association between SDB and worse ex-
ecutive functionbutnotwithglobal cognitionormemory.This
is in linewith2previousmeta-analysesof clinical studies,42,43
which indicated an effect of SDB on executive function, vigi-
lance,andpsychomotorspeed,whilemixedfindingshavebeen
reported on the effects of SDB on memory.42-44 Notably, the
included studies used cognitive tests that varied in the diffi-
cultyofadministration.Moreover,notall studiesexaminedthe
same cognitive domains, and even those that studied similar
domainsmight have used differentmeasures of that domain.
This is particularly an issue for executive function,where cer-
tain componentsmight bemorevulnerable to thenegative ef-
fects of SDB. Therefore, these findings should be interpreted
with caution.
Several mechanisms have been proposed for the associa-
tion between SDB and neurocognitive decline, including
Figure 2. Forest Plot of Cross-sectional Studies on Association Between Sleep-Disordered Breathing
and Cognitive Domains
Weight, %Study SMD (95% CI)
19.8Blackwell et al,27 2011 –0.01 (–0.09 to 0.07)
11.2Foley et al,29 2003 –0.01 (–0.15 to 0.13)
11.2Lutsey et al,17 2016 0.11 (–0.03 to 0.25)
23.6Ramos et al,16 2015 0.00 (–0.06 to 0.06)
27.4Sharafkhaneh et al,34 2005 –0.09 (–0.13 to –0.05)
6.7Spira et al,30 2008 –0.03 (–0.23 to 0.17)
Total (95% CI) -0.02 (-0.07 to 0.04)
Global cognitionA
–0.5 –0.2 0.30.20.10–0.3 –0.1
SMD (95% CI)
–0.4
Weight, %Study SMD (95% CI)
15.0Dlugaj et al,28 2014 0.03 (–0.09 to 0.15)
3.2Hrubos-Strøm et al,32 2012 –0.12 (–0.37 to 0.13)
6.7Lutsey et al,17 2016 0.01 (–0.17 to 0.19)
15.0Nikodemova et al,31 2013 –0.07 (–0.19 to 0.05)
60.1Ramos et al,16 2015 0.00 (–0.06 to 0.06)
Total (95% CI) –0.01 (–0.05 to 0.04)
Delayed memoryC
–0.5 –0.2 0.30.20.10–0.3 –0.1
SMD (95% CI)
–0.4
Weight, %Study SMD (95% CI)
20.5Blackwell et al,27 2011 –0.06 (–0.14 to 0.02)
15.6Dlugaj et al,28 2014 –0.05 (–0.15 to 0.05)
3.5Hrubos-Strøm et al,32 2012 –0.25 (–0.49 to –0.01)
7.7Lutsey et al,17 2016 –0.03 (–0.19 to 0.13)
20.5Nikodemova et al,31 2013 –0.10 (–0.18 to –0.02)
27.1Ramos et al,16 2015 –0.00 (–0.06 to 0.06)
5.2Spira et al,30 2008 0.10 (–0.10 to 0.30)
Total (95% CI) –0.05 (–0.09 to 0.00)
Executive functionB
–0.5 –0.2 0.30.20.10–0.3 –0.1
SMD (95% CI)
–0.4
All effect estimates were pooled
using a weighted random-effects
model. Error bars indicate 95% CIs.
SMD indicates standardmean
difference. A, Forest plot of
association between
sleep-disordered breathing and
global cognition. Heterogeneity:
Τ2 = 0.00; χ2 = 13.35; df = 5; P = .02;
I2 = 63%. Test for overall effect:
z = 0.59; P = .56. B, Forest plot of
association between
sleep-disordered breathing and
executive function. Heterogeneity:
Τ2 = 0.00; χ2 = 9.00; df = 6; P = .17;
I2 = 33%. Test for overall effect:
z = 1.92; P = .05. C, Forest plot of
association between
sleep-disordered breathing and
delayedmemory. Heterogeneity:
Τ2 = 0.00; χ2 = 2.34; df = 4; P = .67;
I2 = 0%. Test for overall effect:
z = 0.37; P = .71.
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hypoxemia, daytime sleepiness, sleep fragmentation, and
oxidative stress.45,46 To date, it remains controversial which
is the most likely mechanism, especially in the absence of
well-designed interventional studies to help disentangle the
causal pathways. Notably, there has been growing attention
on the important role that hypoxemia might play in the rela-
tionship between SDB and cognition.18,45-47 Findings from
the HypnoLaus study,20 the Sleep Heart Health Study,48 the
Apnea Positive Pressure Long-term Efficacy Study,49 and the
Study of Osteoporotic Fractures14 all suggest that degree of
hypoxemia or oxygen desaturation rather than sleep frag-
mentation might affect cognitive performance in middle-
aged and elderly persons. Regular intermittent hypoxia may
cause vascular dysfunction, kill neurons, and impair the
blood-brain barrier, leading to long-term disruption of the
brain’s microenvironment and synaptic plasticity.10,50 A few
studies have suggested that measures of oxygen desaturation
are associated with cognitive impairment.15,18,27,30 Because
measures of oxygen desaturation were only reported in
2 studies included in this meta-analysis, we could not calcu-
late pooled estimates for these measures. Future studies with
consideration of different indices of SDB might provide more
insights into the mechanisms.
Two included studies indicated that the effects of SDB on
cognitionweremorepronounced inAPOE4carriers.30,31While
the exact mechanisms for the interaction between SDB and
APOE4oncognition areunclear, thepresenceofAPOE4geno-
type is believed to increase cellular vulnerability to oxidative
damageandpromoteneuroinflammation.51,52Morestudiesare
needed to investigate the combinedeffects ofAPOE4andSDB
oncognition and tohelpunderstandpotentialmechanismsof
their interaction.
Limitations
A few factors limit the interpretation of our results. First, the
limited amount of empirical data that is appropriate for inclu-
sion in the meta-analysis has led to a few problems. For ex-
ample, prospective studies that examined “clinically signifi-
cant” cognitive decline and MCI or dementia were analyzed
in the samemodel, despite thedifferencesbetween theseout-
comes. However, sensitivity analysis showed similar results
after removing the heterogeneity from the analysis. We fo-
cusedonsummarizingcross-sectionalevidenceon3broadcog-
nitive domains owing to a limited number of studies that ex-
amineddetailed components of the cognitivedomain and the
variations in the cognitive tests administered.Although some
evidencewas found on the relationship between SDB and ex-
ecutive function, the clinical relevanceof these findings is un-
clear, given themodest effect sizes. Future studies shoulduse
comprehensiveneuropsychological testbatteries, andagreater
number of studies is needed to examine the effects of SDB on
specific cognitive abilitiesmore carefully. The scarce informa-
tion from existing studies has also limited our ability to per-
form subgroup analysis, eg, by age. Given the potential
differences in SDB phenotypes among younger vs older
populations,5,53,54 our analysis on the mixture of middle-
aged and older populations might have led to underestima-
tion of the overall association, and we were unable to differ-
entiate the cognitive effects of SDB in different age groups.
Besides, to control for confounding,we includedonly themost
adjusted model within each study. However, the level of ad-
justment in each study was different, andmany studies have
failed to consider potentially important confounders, such as
bodymass index. Therefore, residual confounding remains a
possibility. Finally, we used a clinical diagnosis or an AHI of
15 or greater to define SDB in thepooled analysis, as this is the
cutoff usedbymost previous studies.33 This couldhave intro-
duced misclassification that dilutes the association, espe-
cially given that the 3 different methods of scoring hypop-
neas could yield significantly different AHI values.55 Because
therewere not enough studies formeta-analysis ifwewere to
performtheanalysis separately forAHI3%,AHI3a, andAHI4%,
wechose touse1cutoff in theanalysisbuthavepresentedthese
methods narratively. This approach has also limited our abil-
ity toexamine theassociationbetween the severityof SDBand
cognitiveoutcomes. It ispossible thatwhilenoassociationwas
found between certain cognitive domains and the dichoto-
mized AHI, more severe SDB or other indicators of hypox-
emia might be associated with significantly worse cognition.
Futureepidemiologic studiesshouldconsidercontinuousmea-
suresofAHI tominimize thepossibilityofmisclassificationand
to reveal more information about the severity of SDB.
Conclusions
In summary, this meta-analysis of population-based studies
suggests that individuals with SDB are 26% more likely to
develop cognitive impairment. Given the high prevalence of
both cognitive impairment and SDB, these findings could
have significant clinical implications. Identification of SDB
in elderly persons might help to predict future risk of cogni-
tive impairment. Clinicians should closely follow patients
who experience significant levels of SDB for the occurrence
of cognitive dysfunction and might consider administering
full neuropsychological batteries in some instances. This is
potentially important for the early detection of dementia.
Future studies are required to examine whether treatment of
SDB could benefit cognition and to explore underlying
mechanisms. Ultimately, this might open up new opportuni-
ties for the prevention of cognitive decline and dementia in
elderly persons.
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